APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orlistat

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Orlistat Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchOrlistat Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Orlistat Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Orlistat Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orlistat Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Orlistat Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Orlistat market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orlistat include Teva, Sandoz(Novartis), Roche, GSK group, ZEIN pharmaceutical, Taj Pharmaceuticals Ltd, STADA-VN J.V.Co., Ltd, National Company for Pharmaceutical Industry and Lunan Pharmaceutical Group Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Orlistat market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Orlistat market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Orlistat market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Orlistat.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Orlistat market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Orlistat Market by Company

Teva

Sandoz(Novartis)

Roche

GSK group

ZEIN pharmaceutical

Taj Pharmaceuticals Ltd

STADA-VN J.V.Co., Ltd

National Company for Pharmaceutical Industry

Lunan Pharmaceutical Group Corporation

Kabir Life Sciences & Research

HISUN

Hexal AG

DM Pharma

China Zhongshan Pharm

Orlistat Segment by Type

120mg Orlistat

60mg Orlistat

Orlistat Segment by Application

Weight-reducing Aid

Other

Orlistat Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orlistat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orlistat and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orlistat.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Orlistat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 120mg Orlistat Table 2. Major Company of 60mg Orlistat Table 3. Global Orlistat Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Orlistat Sales by Type (2021-2026) & (K Units) Table 5. Global Orlistat Sales Market Share in Volume by Type (2021-2026) Table 6. Global Orlistat Sales by Type (2021-2026) & (US$ Million) Table 7. Global Orlistat Sales Market Share in Value by Type (2021-2026) Table 8. Global Orlistat Price by Type (2021-2026) & (US$/Unit) Table 9. Global Orlistat Sales by Type (2027-2032) & (K Units) Table 10. Global Orlistat Sales Market Share in Volume by Type (2027-2032) Table 11. Global Orlistat Sales by Type (2027-2032) & (US$ Million) Table 12. Global Orlistat Sales Market Share in Value by Type (2027-2032) Table 13. Global Orlistat Price by Type (2027-2032) & (US$/Unit) Table 14. North America Orlistat Sales by Type (2021-2026) & (K Units) Table 15. North America Orlistat Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Orlistat Sales by Type (2021-2026) & (K Units) Table 17. Europe Orlistat Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Orlistat Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Orlistat Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Orlistat Sales by Type (2021-2026) & (K Units) Table 21. Latin America Orlistat Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Orlistat Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Orlistat Sales by Type (2021-2026) & (US$ Million) Table 24. Orlistat Industry Trends Table 25. Orlistat Industry Drivers Table 26. Orlistat Industry Opportunities and Challenges Table 27. Orlistat Industry Restraints Table 28. Global Orlistat Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Orlistat Revenue Market Share by Company (2021-2026) Table 30. Global Orlistat Sales by Company (2021-2026) & (K Units) Table 31. Global Orlistat Sales Share by Company (2021-2026) Table 32. Global Orlistat Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Orlistat Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Orlistat Major Company Production Sites and Headquarters Table 35. Global Orlistat Company, Product Type & Application Table 36. Global Orlistat Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Orlistat by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Orlistat Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Orlistat Sales by Region (2021-2026) & (K Units) Table 41. Global Orlistat Sales Market Share in Volume by Region (2021-2026) Table 42. Global Orlistat Sales by Region (2021-2026) & (US$ Million) Table 43. Global Orlistat Sales Market Share in Value by Region (2021-2026) Table 44. Global Orlistat Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Orlistat Sales by Region (2027-2032) & (K Units) Table 46. Global Orlistat Sales Market Share in Volume by Region (2027-2032) Table 47. Global Orlistat Sales by Region (2027-2032) & (US$ Million) Table 48. Global Orlistat Sales Market Share in Value by Region (2027-2032) Table 49. Global Orlistat Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Orlistat Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Orlistat Sales by Application (2021-2026) & (K Units) Table 52. Global Orlistat Sales Market Share in Volume by Application (2021-2026) Table 53. Global Orlistat Sales by Application (2021-2026) & (US$ Million) Table 54. Global Orlistat Sales Market Share in Value by Application (2021-2026) Table 55. Global Orlistat Price by Application (2021-2026) & (US$/Unit) Table 56. Global Orlistat Sales by Application (2027-2032) & (K Units) Table 57. Global Orlistat Sales Market Share in Volume by Application (2027-2032) Table 58. Global Orlistat Sales by Application (2027-2032) & (US$ Million) Table 59. Global Orlistat Sales Market Share in Value by Application (2027-2032) Table 60. Global Orlistat Price by Application (2027-2032) & (US$/Unit) Table 61. North America Orlistat Sales by Application (2021-2026) & (K Units) Table 62. North America Orlistat Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Orlistat Sales by Application (2021-2026) & (K Units) Table 64. Europe Orlistat Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Orlistat Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Orlistat Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Orlistat Sales by Application (2021-2026) & (K Units) Table 68. Latin America Orlistat Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Orlistat Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Orlistat Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Orlistat Product Portfolio Table 75. Teva Recent Development Table 76. Sandoz(Novartis) Company Information Table 77. Sandoz(Novartis) Business Overview Table 78. Sandoz(Novartis) Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sandoz(Novartis) Orlistat Product Portfolio Table 80. Sandoz(Novartis) Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Roche Orlistat Product Portfolio Table 85. Roche Recent Development Table 86. GSK group Company Information Table 87. GSK group Business Overview Table 88. GSK group Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GSK group Orlistat Product Portfolio Table 90. GSK group Recent Development Table 91. ZEIN pharmaceutical Company Information Table 92. ZEIN pharmaceutical Business Overview Table 93. ZEIN pharmaceutical Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. ZEIN pharmaceutical Orlistat Product Portfolio Table 95. ZEIN pharmaceutical Recent Development Table 96. Taj Pharmaceuticals Ltd Company Information Table 97. Taj Pharmaceuticals Ltd Business Overview Table 98. Taj Pharmaceuticals Ltd Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Taj Pharmaceuticals Ltd Orlistat Product Portfolio Table 100. Taj Pharmaceuticals Ltd Recent Development Table 101. STADA-VN J.V.Co., Ltd Company Information Table 102. STADA-VN J.V.Co., Ltd Business Overview Table 103. STADA-VN J.V.Co., Ltd Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. STADA-VN J.V.Co., Ltd Orlistat Product Portfolio Table 105. STADA-VN J.V.Co., Ltd Recent Development Table 106. National Company for Pharmaceutical Industry Company Information Table 107. National Company for Pharmaceutical Industry Business Overview Table 108. National Company for Pharmaceutical Industry Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. National Company for Pharmaceutical Industry Orlistat Product Portfolio Table 110. National Company for Pharmaceutical Industry Recent Development Table 111. Lunan Pharmaceutical Group Corporation Company Information Table 112. Lunan Pharmaceutical Group Corporation Business Overview Table 113. Lunan Pharmaceutical Group Corporation Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio Table 115. Lunan Pharmaceutical Group Corporation Recent Development Table 116. Kabir Life Sciences & Research Company Information Table 117. Kabir Life Sciences & Research Business Overview Table 118. Kabir Life Sciences & Research Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Kabir Life Sciences & Research Orlistat Product Portfolio Table 120. Kabir Life Sciences & Research Recent Development Table 121. HISUN Company Information Table 122. HISUN Business Overview Table 123. HISUN Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. HISUN Orlistat Product Portfolio Table 125. HISUN Recent Development Table 126. Hexal AG Company Information Table 127. Hexal AG Business Overview Table 128. Hexal AG Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hexal AG Orlistat Product Portfolio Table 130. Hexal AG Recent Development Table 131. DM Pharma Company Information Table 132. DM Pharma Business Overview Table 133. DM Pharma Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. DM Pharma Orlistat Product Portfolio Table 135. DM Pharma Recent Development Table 136. China Zhongshan Pharm Company Information Table 137. China Zhongshan Pharm Business Overview Table 138. China Zhongshan Pharm Orlistat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. China Zhongshan Pharm Orlistat Product Portfolio Table 140. China Zhongshan Pharm Recent Development Table 141. North America Orlistat Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Orlistat Sales by Country (2021-2026) & (K Units) Table 143. North America Orlistat Sales Market Share by Country (2021-2026) Table 144. North America Orlistat Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Orlistat Sales Market Share Forecast by Country (2027-2032) Table 146. North America Orlistat Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Orlistat Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Orlistat Market Share by Country (2021-2026) Table 149. North America Orlistat Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Orlistat Market Share Forecast by Country (2027-2032) Table 151. Europe Orlistat Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Orlistat Sales by Country (2021-2026) & (K Units) Table 153. Europe Orlistat Sales Market Share by Country (2021-2026) Table 154. Europe Orlistat Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Orlistat Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Orlistat Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Orlistat Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Orlistat Market Share by Country (2021-2026) Table 159. Europe Orlistat Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Orlistat Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Orlistat Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Orlistat Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Orlistat Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Orlistat Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Orlistat Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Orlistat Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Orlistat Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Orlistat Market Share by Country (2021-2026) Table 169. Asia-Pacific Orlistat Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Orlistat Market Share Forecast by Country (2027-2032) Table 171. Latin America Orlistat Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Orlistat Sales by Country (2021-2026) & (K Units) Table 173. Latin America Orlistat Sales Market Share by Country (2021-2026) Table 174. Latin America Orlistat Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Orlistat Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Orlistat Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Orlistat Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Orlistat Market Share by Country (2021-2026) Table 179. Latin America Orlistat Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Orlistat Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Orlistat Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Orlistat Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Orlistat Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Orlistat Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Orlistat Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Orlistat Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Orlistat Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Orlistat Market Share by Country (2021-2026) Table 189. Middle East and Africa Orlistat Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Orlistat Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Orlistat Distributors List Table 194. Orlistat Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Orlistat Image Figure 2. Global Orlistat Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orlistat Market Size (2021-2032) & (US$ Million) Figure 4. Global Orlistat Sales (2021-2032) & (K Units) Figure 5. 120mg Orlistat Image Figure 6. Global 120mg Orlistat Sales YoY Growth (2021-2032) & (K Units) Figure 7. 60mg Orlistat Image Figure 8. Global 60mg Orlistat Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Orlistat Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Orlistat Market Share by Type 2025 VS 2032 Figure 11. North America Orlistat Sales Market Share in Volume by Type in 2025 Figure 12. North America Orlistat Sales Market Share in Value by Type in 2025 Figure 13. Europe Orlistat Sales Market Share in Volume by Type in 2025 Figure 14. Europe Orlistat Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Orlistat Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Orlistat Sales Market Share in Value by Type in 2025 Figure 17. Latin America Orlistat Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Orlistat Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Orlistat Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Orlistat Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Orlistat Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Weight-reducing Aid Image Figure 24. Global Weight-reducing Aid Sales YoY Growth (2021-2032) & (K Units) Figure 25. Other Image Figure 26. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Orlistat Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Orlistat Market Share by Application 2025 VS 2032 Figure 29. North America Orlistat Sales Market Share in Volume by Application in 2025 Figure 30. North America Orlistat Sales Market Share in Value by Application in 2025 Figure 31. Europe Orlistat Sales Market Share in Volume by Application in 2025 Figure 32. Europe Orlistat Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Orlistat Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Orlistat Sales Market Share in Value by Application in 2025 Figure 35. Latin America Orlistat Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Orlistat Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Orlistat Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Orlistat Sales Market Share in Value by Application in 2025 Figure 39. North America Orlistat Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Orlistat Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Orlistat Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Orlistat Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Orlistat Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Orlistat Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Orlistat Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Orlistat Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Orlistat Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Orlistat Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Orlistat Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Orlistat Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Orlistat Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Orlistat Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Orlistat Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Orlistat Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Orlistat Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Orlistat Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Orlistat Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Orlistat Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Orlistat Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Orlistat Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg Orlistat
  • 60mg Orlistat
Applications
  • Weight-reducing Aid
  • Other
Companies covered
  • Teva
  • Sandoz(Novartis)
  • Roche
  • GSK group
  • ZEIN pharmaceutical
  • Taj Pharmaceuticals Ltd
  • STADA-VN J.V.Co., Ltd
  • National Company for Pharmaceutical Industry
  • Lunan Pharmaceutical Group Corporation
  • Kabir Life Sciences & Research
  • HISUN
  • Hexal AG
  • DM Pharma
  • China Zhongshan Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Orlistat Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Orlistat Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Orlistat Market by Type
  6. 1.3.1 120mg Orlistat
  7. 1.3.2 60mg Orlistat
  8. 1.4 Global Orlistat Market Size by Type
  9. 1.4.1 Global Orlistat Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Orlistat Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Orlistat Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Orlistat Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Orlistat Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Orlistat Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Orlistat Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Orlistat Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Orlistat Industry Trends
  2. 2.2 Orlistat Industry Drivers
  3. 2.3 Orlistat Industry Opportunities and Challenges
  4. 2.4 Orlistat Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Orlistat Revenue (2021-2026)
  2. 3.2 Global Top Players by Orlistat Sales (2021-2026)
  3. 3.3 Global Top Players by Orlistat Price (2021-2026)
  4. 3.4 Global Orlistat Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orlistat Major Company Production Sites & Headquarters
  6. 3.6 Global Orlistat Company, Product Type & Application
  7. 3.7 Global Orlistat Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orlistat Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orlistat Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orlistat Tier 1, Tier 2, and Tier 3
4 Orlistat Regional Status and Outlook
  1. 4.1 Global Orlistat Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Orlistat Historic Market Size by Region
  3. 4.2.1 Global Orlistat Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Orlistat Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Orlistat Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Orlistat Forecasted Market Size by Region
  7. 4.3.1 Global Orlistat Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Orlistat Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Orlistat Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Orlistat by Application
  1. 5.1 Orlistat Market by Application
  2. 5.1.1 Weight-reducing Aid
  3. 5.1.2 Other
  4. 5.2 Global Orlistat Market Size by Application
  5. 5.2.1 Global Orlistat Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Orlistat Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Orlistat Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Orlistat Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Orlistat Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Orlistat Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Orlistat Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Orlistat Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Orlistat Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Orlistat Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz(Novartis)
  8. 6.2.1 Sandoz(Novartis) Company Information
  9. 6.2.2 Sandoz(Novartis) Business Overview
  10. 6.2.3 Sandoz(Novartis) Orlistat Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz(Novartis) Orlistat Product Portfolio
  12. 6.2.5 Sandoz(Novartis) Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Orlistat Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Orlistat Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 GSK group
  20. 6.4.1 GSK group Company Information
  21. 6.4.2 GSK group Business Overview
  22. 6.4.3 GSK group Orlistat Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK group Orlistat Product Portfolio
  24. 6.4.5 GSK group Recent Developments
  25. 6.5 ZEIN pharmaceutical
  26. 6.5.1 ZEIN pharmaceutical Company Information
  27. 6.5.2 ZEIN pharmaceutical Business Overview
  28. 6.5.3 ZEIN pharmaceutical Orlistat Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ZEIN pharmaceutical Orlistat Product Portfolio
  30. 6.5.5 ZEIN pharmaceutical Recent Developments
  31. 6.6 Taj Pharmaceuticals Ltd
  32. 6.6.1 Taj Pharmaceuticals Ltd Company Information
  33. 6.6.2 Taj Pharmaceuticals Ltd Business Overview
  34. 6.6.3 Taj Pharmaceuticals Ltd Orlistat Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Taj Pharmaceuticals Ltd Orlistat Product Portfolio
  36. 6.6.5 Taj Pharmaceuticals Ltd Recent Developments
  37. 6.7 STADA-VN J.V.Co., Ltd
  38. 6.7.1 STADA-VN J.V.Co., Ltd Company Information
  39. 6.7.2 STADA-VN J.V.Co., Ltd Business Overview
  40. 6.7.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 STADA-VN J.V.Co., Ltd Orlistat Product Portfolio
  42. 6.7.5 STADA-VN J.V.Co., Ltd Recent Developments
  43. 6.8 National Company for Pharmaceutical Industry
  44. 6.8.1 National Company for Pharmaceutical Industry Company Information
  45. 6.8.2 National Company for Pharmaceutical Industry Business Overview
  46. 6.8.3 National Company for Pharmaceutical Industry Orlistat Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 National Company for Pharmaceutical Industry Orlistat Product Portfolio
  48. 6.8.5 National Company for Pharmaceutical Industry Recent Developments
  49. 6.9 Lunan Pharmaceutical Group Corporation
  50. 6.9.1 Lunan Pharmaceutical Group Corporation Company Information
  51. 6.9.2 Lunan Pharmaceutical Group Corporation Business Overview
  52. 6.9.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio
  54. 6.9.5 Lunan Pharmaceutical Group Corporation Recent Developments
  55. 6.10 Kabir Life Sciences & Research
  56. 6.10.1 Kabir Life Sciences & Research Company Information
  57. 6.10.2 Kabir Life Sciences & Research Business Overview
  58. 6.10.3 Kabir Life Sciences & Research Orlistat Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kabir Life Sciences & Research Orlistat Product Portfolio
  60. 6.10.5 Kabir Life Sciences & Research Recent Developments
  61. 6.11 HISUN
  62. 6.11.1 HISUN Company Information
  63. 6.11.2 HISUN Business Overview
  64. 6.11.3 HISUN Orlistat Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 HISUN Orlistat Product Portfolio
  66. 6.11.5 HISUN Recent Developments
  67. 6.12 Hexal AG
  68. 6.12.1 Hexal AG Company Information
  69. 6.12.2 Hexal AG Business Overview
  70. 6.12.3 Hexal AG Orlistat Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hexal AG Orlistat Product Portfolio
  72. 6.12.5 Hexal AG Recent Developments
  73. 6.13 DM Pharma
  74. 6.13.1 DM Pharma Company Information
  75. 6.13.2 DM Pharma Business Overview
  76. 6.13.3 DM Pharma Orlistat Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 DM Pharma Orlistat Product Portfolio
  78. 6.13.5 DM Pharma Recent Developments
  79. 6.14 China Zhongshan Pharm
  80. 6.14.1 China Zhongshan Pharm Company Information
  81. 6.14.2 China Zhongshan Pharm Business Overview
  82. 6.14.3 China Zhongshan Pharm Orlistat Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 China Zhongshan Pharm Orlistat Product Portfolio
  84. 6.14.5 China Zhongshan Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Orlistat Sales by Country
  2. 7.1.1 North America Orlistat Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Orlistat Sales by Country (2021-2026)
  4. 7.1.3 North America Orlistat Sales Forecast by Country (2027-2032)
  5. 7.2 North America Orlistat Market Size by Country
  6. 7.2.1 North America Orlistat Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Orlistat Market Size by Country (2021-2026)
  8. 7.2.3 North America Orlistat Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Orlistat Sales by Country
  2. 8.1.1 Europe Orlistat Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Orlistat Sales by Country (2021-2026)
  4. 8.1.3 Europe Orlistat Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Orlistat Market Size by Country
  6. 8.2.1 Europe Orlistat Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Orlistat Market Size by Country (2021-2026)
  8. 8.2.3 Europe Orlistat Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Orlistat Sales by Country
  2. 9.1.1 Asia-Pacific Orlistat Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Orlistat Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Orlistat Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Orlistat Market Size by Country
  6. 9.2.1 Asia-Pacific Orlistat Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Orlistat Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Orlistat Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Orlistat Sales by Country
  2. 10.1.1 South America Orlistat Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Orlistat Sales by Country (2021-2026)
  4. 10.1.3 South America Orlistat Sales Forecast by Country (2027-2032)
  5. 10.2 South America Orlistat Market Size by Country
  6. 10.2.1 South America Orlistat Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Orlistat Market Size by Country (2021-2026)
  8. 10.2.3 South America Orlistat Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Orlistat Sales by Country
  2. 11.1.1 Middle East and Africa Orlistat Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Orlistat Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Orlistat Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Orlistat Market Size by Country
  6. 11.2.1 Middle East and Africa Orlistat Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Orlistat Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Orlistat Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Orlistat Value Chain Analysis
  2. 12.1.1 Orlistat Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Orlistat Production Mode & Process
  7. 12.2 Orlistat Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Orlistat Distributors
  10. 12.2.3 Orlistat Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst